Biogen Leasing Eisai Production Space in RTP
|Biogen's new RTP facility. Courtesy of Biogen Idec|
It’s a win-win for two of North Carolina’s most valuable life-science assets: collaboration and biomanufacturing leadership.
Biogen Idec and Eisai unveiled a 10-year manufacturing alliance today that allows Biogen to make some oral solid dose products for both companies at Eisai’s neighboring factory in Research Triangle Park. Biogen will also hire about 50 of Eisai’s 225 employees in early 2013 as part of the lease agreement, adding to Biogen’s RTP workforce of more than 1,000.
The announcement comes just a week after Biogen officially opened a new five-story, 190,000-square-foot building to consolidate employees onto its RTP campus.
"We look forward to collaborating with Biogen Idec to continue the proud history of drug manufacturing excellence here at our RTP site," said Lou Arp, general manager of the Eisai RTP site and president of Global Oncology Manufacturing, for Eisai Inc.
"Our alliance will enable both companies to focus on respective areas of expertise while continuing to deliver high-quality and innovative products to patients. Moreover, employees will benefit by working in a highly collaborative environment that offers opportunities to further cultivate their careers.”
“We view our supply chain as a lifeline to patients, designed to deliver quality therapies wherever and whenever they are needed,” said John G. Cox, executive vice president of Pharmaceutical Operations and Technology, for Biogen Idec. “This innovative capacity-sharing relationship with Eisai fits strategically in our global drug supply network, particularly as we advance our oral therapeutics.”
Massachusetts-based Biogen and Eisai, headquartered in Japan, both established their pharmaceutical manufacturing facilities in RTP in 1995.
“This alliance underscores the Triangle region’s reputation as a globally competitive location for life sciences,” said Bob Geolas, president and CEO of the Research Triangle Foundation. “In addition, it’s an illustration of the type of collaboration we encourage and foresee becoming more commonplace as the Park moves forward with its new master plan.”